Literature DB >> 36264074

FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers.

Nsengiyumva Emmanuel1, Hongen Li2, Jing Chen3, Yilei Zhang1,4.   

Abstract

In the study of "A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers" which was published earlier in Nature Communications, the authors have identified a novel KEAP1/NRF2 target gene, FSP1, and demonstrated that FSP1 plays an essential role in NRF2-mediated ferroptosis resistance and radioresistance in KEAP1-deficient lung cancer cells. Currently, many NRF2 target genes have been found to participate in the regulation of ferroptosis, and exactly which one plays a dominant role seems unclear. This study proposes that FSP1 is the key effector in NRF2-mediated ferroptosis resistance and radioresistance in KEAP-deficient lung cancer cells, as we discussed in the manuscript.

Entities:  

Keywords:  KEAP1/NRF2; ferroptosis; lung cancer; radioresistance; therapy

Mesh:

Substances:

Year:  2022        PMID: 36264074      PMCID: PMC9584440          DOI: 10.18632/oncotarget.28301

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


  15 in total

1.  The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.

Authors:  Pranavi Koppula; Yilei Zhang; Jiejun Shi; Wei Li; Boyi Gan
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

2.  FSP1 is a glutathione-independent ferroptosis suppressor.

Authors:  Sebastian Doll; Florencio Porto Freitas; Ron Shah; Maceler Aldrovandi; Milene Costa da Silva; Irina Ingold; Andrea Goya Grocin; Thamara Nishida Xavier da Silva; Elena Panzilius; Christina H Scheel; André Mourão; Katalin Buday; Mami Sato; Jonas Wanninger; Thibaut Vignane; Vaishnavi Mohana; Markus Rehberg; Andrew Flatley; Aloys Schepers; Andreas Kurz; Daniel White; Markus Sauer; Michael Sattler; Edward William Tate; Werner Schmitz; Almut Schulze; Valerie O'Donnell; Bettina Proneth; Grzegorz M Popowicz; Derek A Pratt; José Pedro Friedmann Angeli; Marcus Conrad
Journal:  Nature       Date:  2019-10-21       Impact factor: 49.962

3.  PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway.

Authors:  Yilong Wang; Shu Yan; Xuemei Liu; Fei Deng; Pengchao Wang; Liuye Yang; Lizhi Hu; Kai Huang; Jiangui He
Journal:  Cell Death Differ       Date:  2022-04-05       Impact factor: 12.067

4.  Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

Authors:  Youngtae Jeong; Ngoc T Hoang; Alexander Lovejoy; Henning Stehr; Aaron M Newman; Andrew J Gentles; William Kong; Diana Truong; Shanique Martin; Aadel Chaudhuri; Diane Heiser; Li Zhou; Carmen Say; Justin N Carter; Susan M Hiniker; Billy W Loo; Robert B West; Philip Beachy; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Discov       Date:  2016-09-23       Impact factor: 39.397

5.  Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2.

Authors:  María Salazar; Ana I Rojo; Diego Velasco; Rosa María de Sagarra; Antonio Cuadrado
Journal:  J Biol Chem       Date:  2006-03-21       Impact factor: 5.157

6.  The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression.

Authors:  Guang Lei; Yilei Zhang; Pranavi Koppula; Xiaoguang Liu; Jie Zhang; Steven H Lin; Jaffer A Ajani; Qin Xiao; Zhongxing Liao; Hui Wang; Boyi Gan
Journal:  Cell Res       Date:  2020-01-16       Impact factor: 25.617

7.  The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.

Authors:  Kirill Bersuker; Joseph M Hendricks; Zhipeng Li; Leslie Magtanong; Breanna Ford; Peter H Tang; Melissa A Roberts; Bingqi Tong; Thomas J Maimone; Roberto Zoncu; Michael C Bassik; Daniel K Nomura; Scott J Dixon; James A Olzmann
Journal:  Nature       Date:  2019-10-21       Impact factor: 49.962

Review 8.  NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis.

Authors:  Matthew Dodson; Raul Castro-Portuguez; Donna D Zhang
Journal:  Redox Biol       Date:  2019-01-11       Impact factor: 11.799

9.  A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.

Authors:  Pranavi Koppula; Guang Lei; Yilei Zhang; Yuelong Yan; Chao Mao; Lavanya Kondiparthi; Jiejun Shi; Xiaoguang Liu; Amber Horbath; Molina Das; Wei Li; Masha V Poyurovsky; Kellen Olszewski; Boyi Gan
Journal:  Nat Commun       Date:  2022-04-22       Impact factor: 17.694

10.  BAP1 links metabolic regulation of ferroptosis to tumour suppression.

Authors:  Yilei Zhang; Jiejun Shi; Xiaoguang Liu; Li Feng; Zihua Gong; Pranavi Koppula; Kapil Sirohi; Xu Li; Yongkun Wei; Hyemin Lee; Li Zhuang; Gang Chen; Zhen-Dong Xiao; Mien-Chie Hung; Junjie Chen; Peng Huang; Wei Li; Boyi Gan
Journal:  Nat Cell Biol       Date:  2018-09-10       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.